缬沙坦联合阿托伐他汀治疗高血压病合并持续性房颤的临床疗效评价  

Clinical Effect Evaluation of Valsartan Combined with Atorvastatin in Treatment of Hypertensive with Persistant Atrial Fibrillation

作　　者：欧吐红 

机构地区：[1]新疆博尔塔拉蒙古自治州博州蒙医医院内科,新疆博尔塔拉833400

出　　处：《中国医药指南》2014年第24期46-47,共2页Guide of China Medicine

摘　　要：目的评价缬沙坦联合阿托伐他汀治疗高血压病合并持续性房颤的临床疗效。方法将122例高血压病合并持续性房颤患者随机分为观察组(n=61)和对照组(n=61),对照组患者给予常规降压、改善心律治疗,在此基础上观察组患者采用缬沙坦联合阿托伐他汀治疗,观察两组患者治疗后的血压情况以及转复率、左房内径(LAD)及左室质量指数(LVMI)。结果观察组患者治疗后的血压水平、转复率、LAD以及LVMI优于对照组患者,组间差异有统计学意义(P<0.05)。结论采用缬沙坦联合阿托伐他汀治疗高血压病合并持续性房颤临床疗效可靠,值得临床进一步推广使用。Objective To evaluate the clinical effect of valsartan combined with atorvastatin in treatment of hypertensive with persistant atrial fibrillation. Methods 122 cases of hypertensive with persistant atrial fibrillation were randomly divided into observation group（n=61）and control group（n=61）, all cases were given routine treatment, based on this cases in the observation group were treated by valsartan combined with atorvastatin, observed the blood pressure, cardioversion rate, left atrial diameter（LAD）and left ventricular mass index（LVMI）of cases in two groups after treatment. Results The level of blood pressure, recovery ratio, LAD and LVMI of cases in observation group was better than that in control group, there was significant difference between two groups（P〈0.05）. Conclusion Taking valsartan combined with atorvastatin in the treatment of hypertensive with persistant atrial fibrillation has good clinical effect, worthy of further clinical application.

关 键 词：高血压 持续性房颤 缬沙坦 阿托伐他汀 临床疗效 

分 类 号：R544.1[医药卫生—心血管疾病]